Showing results (1471-1480 of 2,039) with videos related to
Sort By:
Pageof 204
Tropical Medicine & International Health : TM & IH|October 21, 2010
Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS careMarielle Bemelmans, Thomas van den Akker, Nathan Ford, et al.Plos One|November 19, 2010
Evaluation of three sampling methods to monitor outcomes of antiretroviral treatment programmes in low- and middle-income countriesJean-Michel Tassie, Karen Malateste, Mar Pujades-Rodríguez, et al.Malawi Medical Journal : the Journal of Medical Association of Malawi|August 17, 2016
Changes in Escherichia coli resistance to co-trimoxazole in tuberculosis patients and in relation to co-trimoxazole prophylaxis in Thyolo, MalawiR Zachariah, A D Harries, M P Spielmann, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 10, 2021
Persistence of clinically relevant levels of SARS-CoV2 envelope gene subgenomic RNAs in non-immunocompromised individualsMerlin Davies, Laura R Bramwell, Nicola Jeffery, et al.Public Health Action|September 23, 2015
The burden and outcomes of childhood tuberculosis in Cotonou, BeninS Ade, A D Harries, A Trébucq, et al.Public Health Action|September 23, 2015
Tuberculosis in health care workers in BelarusD Klimuk, H Hurevich, A D Harries, et al.Public Health Action|September 23, 2015
Multi- and extensively drug-resistant tuberculosis in Latvia: trends, characteristics and treatment outcomesL Kuksa, V Riekstina, V Leimane, et al.Public Health Action|October 2, 2015
Screening retreatment tuberculosis patients for drug resistance in mid-west Nepal: how well are we doing?M B Tharu, A D Harries, S Goel, et al.Journal of the International AIDS Society|July 9, 2013
Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South AfricaGabriela E M Patten, Lynne Wilkinson, Karien Conradie, et al.International Journal of Cardiology|August 3, 2019
A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot studyHeba Nashat, Aleksander Kempny, Carl Harries, et al.Pageof 204